...
首页> 外文期刊>Journal of Molecular Biology >Crystal structure at 1.95 angstrom resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition
【24h】

Crystal structure at 1.95 angstrom resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition

机译:乳腺肿瘤特异性抗体SM3及其肽表位复合物在1.95埃分辨率下的晶体结构揭示了新的高变环识别

获取原文
获取原文并翻译 | 示例

摘要

The anti-breast tumour antibody SM3 has a high selectivity in reacting specifically with carcinoma-associated mucin. SM3 recognises the core repeating motif (Pro-Asp-ThP-Arg-Pro) of aberrantly glycosylated epithelial mucin MUC1, and has potential as a therapeutic and diagnostic tool. Here we report the crystal structure of the Fab fragment of SM3 in complex with a 13-residue MUC1 peptide antigen (Thr1P-Ser2P-Ala3-Pro4P-Asp5P-Thr6P-Arg7P-Pro8P-Ala9P-Pro10P- Gly11P-Ser12P-Thr13P). The SM3-MUC1 peptide structure was solved by molecular replacement, and the current model is refined at 1.95 Angstrom resolution with an X-factor of 21.3% and R-free 28.3%. The MUC1 peptide is bound both by non-polar interactions and hydrogen bonds in an elongated groove in the antibody-combining site through interactions with Complimentarity Determining Regions (CDRs), three of the light chain (L1, L2, L3) and two of the heavy chain (H1 and H3). The conformation of the peptide is mainly extended with no discernable standard secondary structure. There is a single non-proline cis-peptide bond in H3 (Va195H-Gly96H-Gln97H-Phe98H-Ala101H-Tyr102H) between Gly96H and Gln97H, which appears to play a role in SM3-peptide antigen interactions, and represents the first such example within an antibody hypervariable loop. The SM3-MUC1 peptide structure has implications for rational therapeutic and diagnostic antibody engineering. (C) 1998 Academic Press. [References: 61]
机译:抗乳腺肿瘤抗体SM3在与癌相关粘蛋白特异性反应中具有高选择性。 SM3识别糖基化的上皮粘蛋白MUC1的核心重复基序(Pro-Asp-ThP-Arg-Pro),并具有作为治疗和诊断工具的潜力。在这里,我们报告与3个残基的MUC1肽抗原(Thr1P-Ser2P-Ala3-Pro4P-Asp5P-Thr6P-Arg7P-Pro8P-Ala9P-Pro10P-Gly11P-Ser12P-Thr13P)复合的SM3 Fab片段的晶体结构。通过分子置换解决了SM3-MUC1肽的结构问题,并以1.95埃的分辨率精制了当前模型,其X因子为21.3%,无R值为28.3%。 MUC1肽通过与互补决定区(CDR),轻链中的三个(L1,L2,L3)和两个中的两个互补决定子相互作用,在抗体结合位点的长槽中通过非极性相互作用和氢键结合。重链(H1和H3)。肽的构象主要延伸而没有可辨别的标准二级结构。 H3中只有一个非脯氨酸顺肽键(Va195H-Gly96H-Gln97H-Phe98H-Ala101H-Tyr102H)在Gly96H和Gln97H之间,似乎在SM3肽抗原相互作用中起作用,这是第一个此类实例在抗体高变环中。 SM3-MUC1肽结构对合理的治疗和诊断抗体工程具有影响。 (C)1998年学术出版社。 [参考:61]

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号